269 related articles for article (PubMed ID: 17827388)
1. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.
Cerhan JR; Ansell SM; Fredericksen ZS; Kay NE; Liebow M; Call TG; Dogan A; Cunningham JM; Wang AH; Liu-Mares W; Macon WR; Jelinek D; Witzig TE; Habermann TM; Slager SL
Blood; 2007 Dec; 110(13):4455-63. PubMed ID: 17827388
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
[TBL] [Abstract][Full Text] [Related]
4. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
[TBL] [Abstract][Full Text] [Related]
5. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
Wang SS; Cerhan JR; Hartge P; Davis S; Cozen W; Severson RK; Chatterjee N; Yeager M; Chanock SJ; Rothman N
Cancer Res; 2006 Oct; 66(19):9771-80. PubMed ID: 17018637
[TBL] [Abstract][Full Text] [Related]
6. Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma.
Deng Q; Zheng T; Lan Q; Lan Y; Holford T; Chen Y; Dai M; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
Eur J Cancer Prev; 2013 Jan; 22(1):77-82. PubMed ID: 22609637
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
Lan Q; Wang SS; Menashe I; Armstrong B; Zhang Y; Hartge P; Purdue MP; Holford TR; Morton LM; Kricker A; Cerhan JR; Grulich A; Cozen W; Zahm SH; Yeager M; Vajdic CM; Schenk M; Leaderer B; Yuenger J; Severson RK; Chatterjee N; Chanock SJ; Zheng T; Rothman N
Br J Haematol; 2011 May; 153(3):341-50. PubMed ID: 21418175
[TBL] [Abstract][Full Text] [Related]
8. A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.
Hosgood HD; Purdue MP; Wang SS; Zheng T; Morton LM; Lan Q; Menashe I; Zhang Y; Cerhan JR; Grulich A; Cozen W; Yeager M; Holford TR; Vajdic CM; Davis S; Leaderer B; Kricker A; Schenk M; Zahm SH; Chatterjee N; Chanock SJ; Rothman N; Hartge P; Armstrong B
Br J Haematol; 2011 Mar; 152(6):721-6. PubMed ID: 21250972
[TBL] [Abstract][Full Text] [Related]
9. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
[TBL] [Abstract][Full Text] [Related]
11. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.
Cerhan JR; Novak AJ; Fredericksen ZS; Wang AH; Liebow M; Call TG; Dogan A; Witzig TE; Ansell SM; Habermann TM; Kay NE; Slager SL
Br J Haematol; 2009 Jun; 145(5):614-23. PubMed ID: 19344414
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.
Lan Q; Morton LM; Armstrong B; Hartge P; Menashe I; Zheng T; Purdue MP; Cerhan JR; Zhang Y; Grulich A; Cozen W; Yeager M; Holford TR; Vajdic CM; Davis S; Leaderer B; Kricker A; Schenk M; Zahm SH; Chatterjee N; Chanock SJ; Rothman N; Wang SS
Blood; 2009 Jul; 114(2):264-7. PubMed ID: 19414860
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic variation of inflammation-related genes and risk of non-Hodgkin lymphoma for Uygur and Han Chinese in Xinjiang.
Gu X; Shen Y; Fu L; Zuo HY; Yasen H; He P; Guo XH; Shi YW; Yusufu M
Asian Pac J Cancer Prev; 2014; 15(21):9177-83. PubMed ID: 25422198
[TBL] [Abstract][Full Text] [Related]
15. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
Purdue MP; Lan Q; Wang SS; Kricker A; Menashe I; Zheng TZ; Hartge P; Grulich AE; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Leaderer BP; Cerhan JR; Yeager M; Cozen W; Jacobs K; Davis S; Rothman N; Chanock SJ; Chatterjee N; Armstrong BK
Carcinogenesis; 2009 Feb; 30(2):275-81. PubMed ID: 19029192
[TBL] [Abstract][Full Text] [Related]
16. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma.
Suthandiram S; Gan GG; Mohd Zain S; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
Tumour Biol; 2015 Mar; 36(3):1819-34. PubMed ID: 25384508
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma.
Forrest MS; Skibola CF; Lightfoot TJ; Bracci PM; Willett EV; Smith MT; Holly EA; Roman E
Br J Haematol; 2006 Jul; 134(2):180-3. PubMed ID: 16740140
[TBL] [Abstract][Full Text] [Related]
19. Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.
Wang SS; Menashe I; Cerhan JR; Cozen W; Severson RK; Davis S; Hutchinson A; Rothman N; Chanock SJ; Bernstein L; Hartge P; Morton LM
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):42-9. PubMed ID: 21148756
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
